Advertisement

Ads Placeholder
Loading...

HUTCHMED (China) Limited

0013.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$23.52
HK$0.26(1.12%)
Hong Kong Market opens in 44h 46m

HUTCHMED (China) Limited (0013.HK) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap20.3B
P/E Ratio5.70
EPS (TTM)$4.15
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$19.29
3 Months$23.56
1 Year Target$22.82

0013.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (0013.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.70 and a market capitalization of 20.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.34%
5-Day Change
-1.84%
1-Month Change
7.006%
3-Month Change
1.20%
6-Month Change
-4.93%
Year-to-Date (YTD) Change
12.32%
1-Year Change
12.27%
3-Year Change
-0.34%
5-Year Change
-61.00%
All-Time (Max) Change
-61.00%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

18,110 Employees
IPO DateJun 30, 2021
CountryHK
Actively Trading

Frequently Asked Questions